Inhibition of microtubules and dynein rescues human immunodeficiency virus type 1 from owl monkey TRIMCyp-mediated restriction in a cellular context-specific fashion

Journal of General Virology

Volumn 96, Issue 4, 2015, Pages 874-886

  Pawlica, Paulina ^a   Dufour, Caroline ^a   Berthoux, Lionel ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CYCLOPHILIN A; CYTOPLASMIC DYNEIN; LUCIFERASE; NOCODAZOLE; PACLITAXEL; PROTEIN P50; SMALL INTERFERING RNA; TRIPARTITE MOTIF PROTEIN 5; CARRIER PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; HYBRID PROTEIN;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL SIZE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME BINDING; ENZYME LOCALIZATION; FEMALE; GENE OVEREXPRESSION; HEAVY CHAIN; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROTUBULE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN RESTRICTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTIVITY; VIRUS INHIBITION; ANIMAL; ANTAGONISTS AND INHIBITORS; AOTIDAE; CAT; CELL LINE; CYTOPLASM; DRUG EFFECTS; HEK293 CELL LINE; HELA CELL LINE; HIV INFECTIONS; TUMOR CELL LINE; VIROLOGY;

AOTUS TRIVIRGATUS; CERCOPITHECIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; MIRIDAE;

ANIMALS; AOTIDAE; CARRIER PROTEINS; CATS; CELL LINE; CELL LINE, TUMOR; CYCLOPHILIN A; CYTOPLASM; DYNEINS; HEK293 CELLS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; MICROTUBULES; RECOMBINANT FUSION PROTEINS;

EID: 84925000178     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000018     Document Type: Article

References (74)

1. Anderson, J. L., Campbell, E. M., Wu, X., Vandegraaff, N., Engelman, A. & Hope, T. J. (2006). Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J Virol 80, 9754-9760.
2. Berthoux, L., Towers, G. J., Gurer, C., Salomoni, P., Pandolfi, P. P. & Luban, J. (2003). As2O3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J Virol 77, 3167-3180.
3. Berthoux, L., Sebastian, S., Sayah, D. M. & Luban, J. (2005a). Disruption of human TRIM5a antiviral activity by nonhuman primate orthologues. J Virol 79, 7883-7888.
4. Berthoux, L., Sebastian, S., Sokolskaja, E. & Luban, J. (2005b). Cyclophilin A is required for TRIM5a-mediated resistance to HIV-1 in Old World monkey cells. Proc Natl Acad Sci U S A 102, 14849-14853.
5. Bé rubé, J., Bouchard, A. & Berthoux, L. (2007). Both TRIM5a and TRIMCyp have only weak antiviral activity in canine D17 cells. Retrovirology 4, 68.
6. Biris, N., Tomashevski, A., Bhattacharya, A., Diaz-Griffero, F. & Ivanov, D. N. (2013). Rhesus monkey TRIM5a SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the HIV-1 mature viral core. J Mol Biol 425, 5032-5044.
7. Black, L. R. & Aiken, C. (2010). TRIM5a disrupts the structure of assembled HIV-1 capsid complexes in vitro. J Virol 84, 6564-6569.
8. Brennan, G., Kozyrev, Y. & Hu, S. L. (2008). TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc Natl Acad Sci U S A 105, 3569-3574.
9. Burkhardt, J. K., Echeverri, C. J., Nilsson, T. & Vallee, R. B. (1997). Overexpression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelle distribution. J Cell Biol 139, 469-484.
10. Campbell, E. M., Dodding, M. P., Yap, M. W., Wu, X., Gallois-Montbrun, S., Malim, M. H., Stoye, J. P. & Hope, T. J. (2007). TRIM5 a cytoplasmic bodies are highly dynamic structures. Mol Biol Cell 18, 2102-2111.
11. Campbell, E. M., Perez, O., Anderson, J. L. & Hope, T. J. (2008). Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5a. J Cell Biol 180, 549-561.
12. Carson, S. D. & Pirruccello, S. J. (2013). HeLa cell heterogeneity and coxsackievirus B3 cytopathic effect: implications for inter-laboratory reproducibility of results. J Med Virol 85, 677-683.
13. Carthagena, L., Parise, M. C., Ringeard, M., Chelbi-Alix, M. K., Hazan, U. & Nisole, S. (2008). Implication of TRIM a and TRIMCyp in interferon-induced anti-retroviral restriction activities. Retrovirology 5, 59.
14. Danielson, C. M., Cianci, G. C. & Hope, T. J. (2012). Recruitment and dynamics of proteasome association with rhTRIM5a cytoplasmic complexes during HIV-1 infection. Traffic 13, 1206-1217.
15. De Iaco, A. & Luban, J. (2014). Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA. Retrovirology 11, 11.
16. Diaz-Griffero, F., Li, X., Javanbakht, H., Song, B., Welikala, S., Stremlau, M. & Sodroski, J. (2006a). Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 349, 300-315.
17. Diaz-Griffero, F., Vandegraaff, N., Li, Y., McGee-Estrada, K., Stremlau, M., Welikala, S., Si, Z., Engelman, A. & Sodroski, J. (2006b). Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 351, 404-419.
18. Diaz-Griffero, F., Kar, A., Lee, M., Stremlau, M., Poeschla, E. & Sodroski, J. (2007). Comparative requirements for the restriction of retrovirus infection by TRIM5a and TRIMCyp. Virology 369, 400-410.
19. Dodding, M. P. & Way, M. (2011). Coupling viruses to dynein and kinesin-1. EMBO J 30, 3527-3539.
20. Fricke, T., White, T. E., Schulte, B., de Souza Aranha Vieira, D. A., Dharan, A., Campbell, E. M., Brandariz-Nuñez, A. & Diaz-Griffero, F. (2014). MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1. Retrovirology 11, 68.
21. Ganser-Pornillos, B. K., Chandrasekaran, V., Pornillos, O., Sodroski, J. G., Sundquist, W. I. & Yeager, M. (2011). Hexagonal assembly of a restricting TRIM5a protein. Proc Natl Acad Sci U S A 108, 534-539.
22. Gong, J., Shen, X. H., Qiu, H., Chen, C. & Yang, R. G. (2011). Rhesus monkey TRIM5a has distinct HIV-1 restriction activity among different mammalian cell lines. Curr Microbiol 63, 531-537.
23. Goujon, C., Moncorgé, O., Bauby, H., Doyle, T., Ward, C. C., Schaller, T., Hué, S., Barclay, W. S., Schulz, R. & Malim, M. H. (2013). Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502, 559-562.
24. Han, K., Lou, D. I. & Sawyer, S. L. (2011). Identification of a genomic reservoir for new TRIM genes in primate genomes. PLoS Genet 7, e1002388.
25. Harris, R. S., Hultquist, J. F. & Evans, D. T. (2012). The restriction factors of human immunodeficiency virus. J Biol Chem 287, 40875- 40883.
26. Hatziioannou, T., Cowan, S., Goff, S. P., Bieniasz, P. D. & Towers, G. J. (2003). Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J 22, 385-394.
27. Hatziioannou, T., Perez-Caballero, D., Yang, A., Cowan, S. & Bieniasz, P. D. (2004). Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5a. Proc Natl Acad Sci U S A 101, 10774-10779.
28. He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W. & other authors (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385, 645-649.
29. Ho, D. D., Rota, T. R., Kaplan, J. C., Hartshorn, K. L., Andrews, C. A., Schooley, R. T & Hirsch, M. S. (1985). Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet 325, 602-604.
30. Höök, P. & Vallee, R. B. (2006). The dynein family at a glance. J Cell Sci 119, 4369-4371.
31. Hornick, J. E., Bader, J. R., Tribble, E. K., Trimble, K., Breunig, J. S., Halpin, E. S., Vaughan, K. T. & Hinchcliffe, E. H. (2008). Live-cell analysis of mitotic spindle formation in taxol-treated cells. Cell Motil Cytoskeleton 65, 595-613.
32. Hsieh, M. J., White, P. J. & Pouton, C. W. (2010). Interaction of viruses with host cell molecular motors. Curr Opin Biotechnol 21, 633-639.
33. Hulme, A. E., Perez, O. & Hope, T. J. (2011). Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc Natl Acad Sci U S A 108, 9975-9980.
34. Jordan, M. A. & Wilson, L. (2004). Microtubules as a target for anticancer drugs. Nat Rev Cancer 4, 253-265.
35. Jordan, M. A., Thrower, D. & Wilson, L. (1992). Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J Cell Sci 102, 401-416.
36. Kane, M., Yadav, S. S., Bitzegeio, J., Kutluay, S. B., Zang, T., Wilson, S. J., Schoggins, J. W., Rice, C. M., Yamashita, M. & other authors (2013). MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502, 563-566.
37. Keckesova, Z., Ylinen, L. M. & Towers, G. J. (2004). The human and African green monkey TRIM5a genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A 101, 10780-10785.
38. Lehmann, M., Milev, M. P., Abrahamyan, L., Yao, X. J., Pante, N. & Mouland, A. J. (2009). Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning. J Biol Chem 284, 14572-14585.
39. Liu, Z., Pan, Q., Ding, S., Qian, J., Xu, F., Zhou, J., Cen, S., Guo, F. & Liang, C. (2013). The interferon-inducible MxB protein inhibits HIV- 1 infection. Cell Host Microbe 14, 398-410.
40. Lu, J., Pan, Q., Rong, L., He, W., Liu, S. L. & Liang, C. (2011). The IFITM proteins inhibit HIV-1 infection. J Virol 85, 2126-2137.
41. Luduena, R. F. & Roach, M. C. (1991). Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents. Pharmacol Ther 49, 133-152.
42. Lukic, Z., Hausmann, S., Sebastian, S., Rucci, J., Sastri, J., Robia, S. L., Luban, J. & Campbell, E. M. (2011). TRIM5a associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology 8, 93.
43. Lukic, Z., Dharan, A., Fricke, T., Diaz-Griffero, F. & Campbell, E. M. (2014). HIV-1 uncoating is facilitated by dynein and kinesin 1.J Virol 88, 13613-13625.
44. Malim, M. H. & Bieniasz, P. D. (2012). HIV restriction factors and mechanisms of evasion. Cold Spring Harb Perspect Med 2, a006940.
45. McEwan, W. A., Schaller, T., Ylinen, L. M., Hosie, M. J., Towers, G. J. & Willett, B. J. (2009). Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. J Virol 83, 8270-8275.
46. Melkonian, K. A., Maier, K. C., Godfrey, J. E., Rodgers, M. & Schroer, T. A. (2007). Mechanism of dynamitin-mediated disruption of dynactin. J Biol Chem 282, 19355-19364.
47. Mouland, A. J. & Milev, M. P. (2012). Role of dynein in viral pathogenesis. In Dyneins: Structure, Biology and Disease, pp. 561-583. Edited by S. M. King. Oxford: Elsevier.
48. Nepveu-Traversy, M. E., Bérubé, J. & Berthoux, L. (2009). TRIM5a and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors. Retrovirology 6, 100.
49. Newman, R. M., Hall, L., Kirmaier, A., Pozzi, L. A., Pery, E., Farzan, M., O’Neil, S. P. & Johnson, W. (2008). Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog 4, e1000003.
50. Nisole, S., Lynch, C., Stoye, J. P. & Yap, M. W. (2004). A Trim5- cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci U S A 101, 13324-13328.
51. Pawlica, P. & Berthoux, L. (2014). Cytoplasmic dynein promotes HIV-1 uncoating. Viruses 6, 4195-4211.
52. Pawlica, P., Le Sage, V., Poccardi, N., Tremblay, M. J., Mouland, A. J. & Berthoux, L. (2014). Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5a-mediated restriction of retroviruses. J Virol 88, 5661-5676.
53. Perez-Caballero, D., Hatziioannou, T., Zhang, F., Cowan, S. & Bieniasz, P. D. (2005). Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol 79, 15567-15572.
54. Price, A. J., Marzetta, F., Lammers, M., Ylinen, L. M., Schaller, T., Wilson, S. J., Towers, G. J. & James, L. C. (2009). Active site remodeling switches HIV specificity of antiretroviral TRIMCyp. Nat Struct Mol Biol 16, 1036-1042.
55. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S. & other authors (2001). The tripartite motif family identifies cell compartments. EMBO J 20, 2140-2151.
56. Sardiello, M., Cairo, S., Fontanella, B., Ballabio, A. & Meroni, G. (2008). Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol Biol 8, 225.
57. Sayah, D. M., Sokolskaja, E., Berthoux, L. & Luban, J. (2004). Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569-573.
58. Schiff, P. B., Fant, J. & Horwitz, S. B. (1979). Promotion of microtubule assembly in vitro by taxol. Nature 277, 665-667.
59. Schrader, M., King, S. J., Stroh, T. A. & Schroer, T. A. (2000). Real time imaging reveals a peroxisomal reticulum in living cells. J Cell Sci 113, 3663-3671.
60. Sebastian, S. & Luban, J. (2005). TRIM5a selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2, 40.
61. Shi, J., Friedman, D. B. & Aiken, C. (2013). Retrovirus restriction by TRIM5 proteins requires recognition of only a small fraction of viral capsid subunits. J Virol 87, 9271-9278.
62. Skillman, D. R., Malone, J. L., Decker, C. F., Wagner, K. F., Mapou, R. L., Liao, M. J., Testa, D. & Meltzer, M. S. (1996). Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: evidence for drug safety, tolerance, and antiviral activity. J Infect Dis 173, 1107-1114.
63. Song, B., Gold, B., O’Huigin, C., Javanbakht, H., Li, X., Stremlau, M., Winkler, C., Dean, M. & Sodroski, J. (2005). The B30.2(SPRY) domain of the retroviral restriction factor TRIM5a exhibits lineage-specific length and sequence variation in primates. J Virol 79, 6111-6121.
64. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P. & Sodroski, J. (2004). The cytoplasmic body component TRIM5a restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
65. Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I. & Sodroski, J. (2006). Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5a restriction factor. Proc Natl Acad Sci U S A 103, 5514-5519.
66. Towers, G. J., Hatziioannou, T., Cowan, S., Goff, S. P., Luban, J. & Bieniasz, P. D. (2003). Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 9, 1138-1143.
67. Virgen, C. A., Kratovac, Z., Bieniasz, P. D. & Hatziioannou, T. (2008). Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc Natl Acad Sci U S A 105, 3563-3568.
68. Wilson, S. J., Webb, B. L., Ylinen, L. M., Verschoor, E., Heeney, J. L. & Towers, G. J. (2008). Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc Natl Acad Sci U S A 105, 3557-3562.
69. Yamamoto, J. K., Barré -Sinoussi, F., Bolton, V., Pedersen, N. C. & Gardner, M. B. (1986). Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res 6, 143-152.
70. Yang, Y., Brandariz-Nuñez, A., Fricke, T., Ivanov, D. N., Sarnak, Z. & Diaz-Griffero, F. (2014). Binding of the rhesus TRIM5a PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction. Virology 448, 217-228.
71. Yap, M. W., Nisole, S., Lynch, C. & Stoye, J. P. (2004). TRIM5a protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101, 10786-10791.
72. Zhao, G., Ke, D., Vu, T., Ahn, J., Shah, V. B., Yang, R., Aiken, C., Charlton, L. M., Gronenborn, A. M. & Zhang, P. (2011). Rhesus TRIM5a disrupts the HIV-1 capsid at the inter-hexamer interfaces. PLoS Pathog 7, e1002009.
73. Zheng, Y. H., Jeang, K. T. & Tokunaga, K. (2012). Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology 9, 112.
74. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L. & Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15, 871-875.